Cannula-based vibrating mesh nebulizer
Systems and methods for providing respiratory therapy are disclosed. One device includes a nasal cannula comprising at least at one nasal prong, tubing and a breathing gas conduit. The nasal prong has a proximal tip and a distal end connected to the breathing gas conduit. The breathing gas conduit has an inlet port, an outlet port, and a walled flow path connecting the inlet and outlet ports, such that the conduit directs the breathing gas from the tubing to the proximal tip of the nasal prong. A nebulizer is secured to the nasal cannula and operable to aerosolize a medicament via a vibrating mesh. The vibrating mesh is secured to the nasal cannula and is positioned adjacent to the breathing gas conduit such that the aerosol is entrained with the breathing gas at proximal tip of the nasal prong.
1. A nebulizer for generating a flow of aerosolized medicament for delivery to a patient, the nebulizer comprising:
a chamber having an inlet, an outlet in fluid communication with a nasal cannula, and a pressure port;
a feed tube coupled to the inlet of the chamber for delivery of a liquid medicament from a remote source to the chamber;
an aerosol generator positioned within the nasal cannula and coupled to the outlet of the chamber and operable to aerosolize the liquid medicament, the aerosol generator having an inner surface in fluidic contact with the liquid medicament, and an outer surface from which the aerosolized medicament is released for delivery to the patient, wherein the outlet of the chamber is positioned in line with at least one nasal prong of the nasal cannula, the nebulizer and the nasal cannula configured to deliver a flow of breathing gas to the patient for inhalation so that the flow of aerosolized medicament is entrained into the flow of breathing gas within the nasal cannula and prior to delivery to the patient via the at least one nasal prong;
a nozzle within the chamber, the nozzle connected to the inlet and configured such that the liquid medicament is drip fed onto the inner surface of the aerosol generator at atmospheric pressure under the action of gravity; and
a pressure adjustment element in communication with the pressure port and configured to regulate the pressure within the chamber such that the pressure at the inner and outer surfaces of the aerosol generator is substantially the same.
2. The nebulizer of claim 1 , wherein the aerosol generator is a vibrating mesh.
3. The nebulizer of claim 1 , wherein the pressure at the inner and outer surfaces of the aerosol generator is maintained at atmospheric pressure.
4. The nebulizer of claim 1 , wherein the pressure adjustment element comprises a permeable membrane.
5. The nebulizer of claim 4 , wherein the pressure adjustment element additionally comprises a perforated vent.
6. The nebulizer of claim 4 , wherein the permeable membrane comprises a Gore-Tex material.
7. The nebulizer of claim 1 , wherein the pressure port and outlet are vertically positioned such that the pressure port is located at a topmost section of the chamber, and the outlet is located at the bottommost section of the chamber.
8. The nebulizer of claim 1 , wherein the nebulizer further comprises a piezoelectric ring that is connected to the aerosol generator.
9. The nebulizer of claim 8 , wherein the aerosol generator is operable to aerosolize the liquid medicament upon receipt of an electric signal via electrical contacts connected to the piezoelectric ring.
10. The nebulizer of claim 1 , wherein the nebulizer contains O-rings around the outlet to achieve a liquid tight seal between the chamber and the atmosphere.
11. The nebulizer of claim 1 , wherein the liquid medicament comprises at least one of: bronchodilators, surfactants and antibiotics.
12. The nebulizer of claim 1 , wherein the medicament comprises at least one of: Albuterol (Ventolin), Salbutamol (Proventil), Levosalbutamol/Levalbuterol (Xopenex), Curosurf (Chiesi Pharmaceuticals), Alveofact (Boehringer Ingelheim), Survanta (Abbott Laboratories), Exosurf (Glaxo Wellcome), Surfaxin (Discovery Laboratories), macrolides, erythromycin, clarithromycin, azithromycin, glycopeptides, vancomycin, teicoplanin, oxazoldinone, quinupristin/dalfopristen, aminoglycosides, gentamicin, tobramycin, amikacin, streptomycin, netilmicin, quinolones, ciprofloxacin, ofloxacin, levofloxacin, tetracyclines, oxytetracycline, doxycycline, minocycline, cotrimoxazole, colistin, imepinim, and meripenim.
13. A system for providing respiratory therapy to a patient, the system comprising:
a nasal cannula having at least at one nasal prong, tubing configured to receive breathing gas from a breathing gas source, and a breathing gas conduit disposed between the nasal prong and the tubing, the nasal cannula configured to deliver a flow of breathing gas from the at least one nasal prong;
the nebulizer according to claim 1 , operable to generate a flow of aerosolized medicament; and
a reservoir of liquid medicament located remote from the nebulizer and arranged to supply the nebulizer with the liquid medicament,
wherein the outlet of the chamber is positioned in line with the at least one nasal prong of the nasal cannula, the nebulizer and the nasal cannula configured to deliver the flow of breathing gas and the flow of aerosolized medicament to the patient for inhalation so that the flow of aerosolized medicament is entrained into the flow of breathing gas within the nasal cannula and prior to delivery to the patient via the at least one nasal prong.
14. The system of claim 13 , further comprising a source of breathing gas.